- Home
- ATHA vs ARTW Comparison
ATHA vs ARTW Comparison
Compare ATHA & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- ARTW
- Stock Information
- Founded
- ATHA 2011
- ARTW 1956
- Country
- ATHA United States
- ARTW United States
- Employees
- ATHA N/A
- ARTW N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- ARTW Industrial Machinery/Components
- Sector
- ATHA Health Care
- ARTW Industrials
- Exchange
- ATHA Nasdaq
- ARTW Nasdaq
- Market Cap
- ATHA 10.6M
- ARTW 9.3M
- IPO Year
- ATHA 2020
- ARTW N/A
- Fundamental
- Price
- ATHA $0.31
- ARTW $2.04
- Analyst Decision
- ATHA Buy
- ARTW
- Analyst Count
- ATHA 4
- ARTW 0
- Target Price
- ATHA $11.25
- ARTW N/A
- AVG Volume (30 Days)
- ATHA 1.3M
- ARTW 14.4K
- Earning Date
- ATHA 07-31-2025
- ARTW 07-07-2025
- Dividend Yield
- ATHA N/A
- ARTW N/A
- EPS Growth
- ATHA N/A
- ARTW N/A
- EPS
- ATHA N/A
- ARTW 0.14
- Revenue
- ATHA N/A
- ARTW $23,916,932.00
- Revenue This Year
- ATHA N/A
- ARTW N/A
- Revenue Next Year
- ATHA N/A
- ARTW N/A
- P/E Ratio
- ATHA N/A
- ARTW $40.12
- Revenue Growth
- ATHA N/A
- ARTW N/A
- 52 Week Low
- ATHA $0.22
- ARTW $1.40
- 52 Week High
- ATHA $3.67
- ARTW $4.15
- Technical
- Relative Strength Index (RSI)
- ATHA 49.52
- ARTW 59.35
- Support Level
- ATHA $0.29
- ARTW $1.73
- Resistance Level
- ATHA $0.35
- ARTW $2.00
- Average True Range (ATR)
- ATHA 0.03
- ARTW 0.12
- MACD
- ATHA -0.00
- ARTW 0.01
- Stochastic Oscillator
- ATHA 14.10
- ARTW 94.07
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.